Competitive Advantage in New Patent Regime: A Study of the Indian Pharmaceutical Industry

Indore Management Journal, Special Issue 2012

18 Pages Posted: 9 Apr 2012 Last revised: 25 Feb 2019

See all articles by Abhinava Singh

Abhinava Singh

Chimanbhai Patel Institute of Management & Research; CPIMR

Date Written: April 9, 2012

Abstract

The introduction of product patent regime in 2005 forced the firms in the Indian Pharmaceutical Industry (IPI) to rethink their sources of competitive advantage. The absence of an appropriate funding mechanism through the Indian government and the acquisition of Indian pharmaceutical firms by MNCs have added to the woes. This study mainly focuses on how firms in the IPI would respond in such a scenario.

Keywords: Indian Pharmaceutical Industry, productpatent regime, competitive advantage, resource-based view (RBV), government support, strategic options, key capabilities

Suggested Citation

Singh, Abhinava and Singh, Abhinava, Competitive Advantage in New Patent Regime: A Study of the Indian Pharmaceutical Industry (April 9, 2012). Indore Management Journal, Special Issue 2012, Available at SSRN: https://ssrn.com/abstract=2036857 or http://dx.doi.org/10.2139/ssrn.2036857

Abhinava Singh (Contact Author)

CPIMR ( email )

Ahmedabad
India

Chimanbhai Patel Institute of Management & Research ( email )

Opposite Karnavati Club
S. G. Highway
Ahmedabad, Gujarat 380015
India
+919898144619 (Phone)

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
206
Abstract Views
1,132
rank
205,984
PlumX Metrics